Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

OTC

Galera Therapeutics
Public Companies

Galera Therapeutics Sells Dismutase Mimetics Portfolio to Biossil in $108.5 Million Deal

October 30, 2025October 29, 2025 - by Timothy Alexander

MALVERN, PA — Galera Therapeutics, Inc. (OTC: GRTX) announced it has entered into an asset purchase agreement with Toronto-based Biossil Inc. for the sale of its dismutase mimetics portfolio, including …

Galera Therapeutics Sells Dismutase Mimetics Portfolio to Biossil in $108.5 Million Deal Read More

Galera Therapeutics
Mergers and Acquisitions

Galera Therapeutics Acquires Nova Pharmaceuticals to Advance Breast Cancer Treatment

January 2, 2025December 31, 2024 - by Timothy Alexander

MALVERN, PA — Galera Therapeutics, Inc. (OTC: GRTX) has announced its acquisition of Nova Pharmaceuticals, Inc., a biotechnology company focused on treating resistant forms of breast cancer, including metaplastic and …

Galera Therapeutics Acquires Nova Pharmaceuticals to Advance Breast Cancer Treatment Read More

Trending News

  • Holiday Magic Returns as ‘Happy Holidays from ROX’ Expands With Bigger Festivities

  • Why a Quarter-Century-Old Teacher Award Still Transforms Classrooms Across Our Region

  • Holiday Heat Hits the Stage as Chris’ Jazz Café Unveils Dazzling December Lineup

  • Beloved Delco Holiday Rink Returns With Bigger Thrills, New Events, and a Mission to Give Back

  • Neuronetics to Spotlight Expanding Mental Health Therapies at Major Industry Forum

Subscribe for Updates

Follow Us

  • Facebook
  • X
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Brian Jarratt

Contractor on the Run? Westtown–East Goshen Police Seek Man in Fraud Case

November 26, 2025November 26, 2025

Vanguard Charitable

Charitable Surge Revealed as Americans Boost Giving and DAF Donors Fuel Record Support

November 25, 2025November 25, 2025

Judge

Terrifying Home-Invasion Plot Unravels as Philly Man Gets More Than 22 Years

November 25, 2025November 25, 2025

Copyright © 2025 MyChesCo.